Nine cases of interstitial lung disease associated with anti-CADM140 antibody positive dermatomyositis

Y. Waseda, H. Takato, S. Watanabe, R. Matsunuma, K. Inuzuka, Y. Ichikawa, N. Katayama, M. Yasui, K. Kasahara, M. Fujimura (Kanazawa, Japan)

Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Session: Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Session type: Thematic Poster Session
Number: 716
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Waseda, H. Takato, S. Watanabe, R. Matsunuma, K. Inuzuka, Y. Ichikawa, N. Katayama, M. Yasui, K. Kasahara, M. Fujimura (Kanazawa, Japan). Nine cases of interstitial lung disease associated with anti-CADM140 antibody positive dermatomyositis. Eur Respir J 2012; 40: Suppl. 56, 716

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical features and CT findings of anti-Jo-1 antibody positive interstitial lung disease with or without polymyositis and dermatomyositis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013


The prevalence and subtypes of interstitial lung disease in polymyositis and dermatomyositis patients
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008

Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody
Source: Eur Respir Rev 2015; 24: 370-372
Year: 2015


Utility of myositis related antibodies in interstitial lung disease and suspected autoimmunity.
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019


Autoantibodies to the surfactant protein D in patients with interstitial lung diseases associated with amyopathic dermatomyositis and systemic sclerosis
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008

Interstitial lung diseases associated with amyopathic dermatomyositis
Source: Eur Respir J 2006; 28: 1005-1012
Year: 2006



Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005

Characterization of interstitial pneumonia associated with clinical amyopathic dermatomyositis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Interstitial lung disease (ILD) in association with polymyositis-dermatomyositis (PM/DM) with predominant lymphocytic alveolitis and anti-Jo-1-antibodies
Source: Eur Respir J 2002; 20: Suppl. 38, 586s
Year: 2002

Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies
Source: International Congress 2016 – Connective tissue disorders
Year: 2016


Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020

Anti-a-enolase antibodies in systemic sclerosis identify a subset of patients with diffuse cutaneous sclerosis and interstitial lung disease
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008

Differences between ANCA positive and negative lung fibrosis cases without vasculitis
Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Year: 2019


Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis
Source: Eur Respir J 2003; 22: 245-250
Year: 2003



Long-term outcome of 53 patients with anti-Jo-1 antibody-positive interstitial lung disease
Source: International Congress 2017 – Rare diseases
Year: 2017

A clinicopathological review of interstitial pneumonia with marked IgG4 positive plasma cells infiltration
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Interstitial lung disease (ILD) in patients with polymyositis/dermatomyositis (PM/DM): clinical features and response to treatment in 6 cases
Source: Eur Respir J 2001; 18: Suppl. 33, 528s
Year: 2001

Clinical features of interstitial lung disease in polymyositis and dermatomyositis
Source: Eur Respir J 2006; 28: Suppl. 50, 828s
Year: 2006

p-ANCA positive Hashimoto‘s thyroiditis with interstitial pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 83s
Year: 2005